Dr. Kazuaki Kakehi obtained his PhD degree at Osaka University (Osaka, Japan) in 1975, and is professor of School of pharmacy, Kinki University (Higashi-Osaka, Japan). At the initial step of his carrier, he was interested in synthetic chemistry of glycans, and succeeded in the synthesis of homo-oligosaccharides of 1-6 glucans. Then, he has been developing various methods for quantitative analysis of carbohydrates using GC, HPLC, CE, and microchip electrophoresis. He has published more than 150 scientific papers and review articles and some book chapters. He also obtained patents on the methodologies for the analysis of glycoproteins and glycoconjugates.

N- and O-glycans in biological samples. At present, he is especially interested in proteoglycomics using CE/HPLC-MS techniques, and applies the methods to find clinical glycomarkers of some specific diseases. He is also interested in regulation studies on biopharmaceuticals and tissue engineering/regenerative medicine as a member of staffs of Japanese Pharmacopoeia.

Dr. Xue-Long Sun is an Associate Professor and has been promoted to a Full Professor (2012) in the Department of Chemistry, Cleveland State University and holds an adjunct faculty position at the Department of Molecular Cardiology, Cleveland Clinic since 2007. Dr. Sun earned his Ph.D. degree in Pharmaceutical Chemistry from Kitasato University School of Pharmacy, Tokyo, Japan. He has published 73 peer-reviewed research articles and book chapters. He has been trained as carbohydrate chemist working on synthesis and characterization of sialic acid derivatives during graduate research and glycosaminoglycan mimetics during postdoctoral research. Recently, he is working on glyco-macroligand-based microarray and biosensor for proteomics, pathogen identification; glyco-affinity macroligand engineering for glycoproteomics and glycomics research. In addition, he has worked on synthesis and characterization of lipid and glycolipid derivatives for more than ten years. He has been a Guest Editor for a Special Issue (2010, 30 (2)) of Carbohydrate Recognition and Applications for Medicinal Research Reviews (Wiley InterScience).

Dr. Sun has a wide experience of pharmaceutical and biomedical researches. First, he had worked on anti-influenza agent (Medicinal Chemistry) at RIKEN Institute (Japan) as a basic science special research fellow, and then worked on antithrombotic biomaterials (Biomedical Engineering) at Emory University School of Medicine as a NIH-funded research fellow. Currently, three major research projects are carried out in his group. First is glyco-macroligand engineering for proteomics, pathogen identification and targeted drug delivery applications; second is glyco-affinity macroligand engineering for glycoproteomics and glycomics research; third is exploring endothelial mimetic anithrombotic agents.

Koichi Kato received his Ph.D. in 1991 at Graduate School of Pharmaceutical Sciences, the University of Tokyo (Prof. Yoji Arata), and continued his research as an Assistant Professor and then as a Lecturer in the same group.  In 2000 he received the Award for Young Scientists of the Pharmaceutical Society of Japan and moved to his current position at Nagoya City University.  His research interests include development of NMR techniques for structural analyses of glycoproteins.  Since 2005 he has been a Director of GLYENCE, a company to exploit glycotechnology of his group.  Since 2006 he has also been a Visiting Professor at the Glycoscience Institute, Ochanomizu University.  Since 2008 He has been a Professor at Institute for Molecular Science, holding posts concurrently at Nagoya City University.

His research interests include development of NMR techniques for structural analyses of glycoproteins.

I, Cheorl-Ho Kim, am Director and Professor of Molecular and Cellular Glycobiology Unit, Department of Biological Science, Natural Science Faculty, Sungkyunkwan University, Suwon, Korea.

I am an Expert in field of glycomics and glycobiology, expecially on sphingolipid, ceramide and sialic acid-containing sphingolipids named ganglioside. Please serach for my papers in the leading journal, Glycobiology, Oxford Publishing.

My field is recently foccused on the ganglioside, a sialic aid-containing glycosphingolipids, such as GD3, GM3, lactosyl ceramide or etc.

Narasimham L Parinandi is the Associate Professor in Department of Internal Medicine The Ohio State University College of Medicine USA He earned his PhD 19801986 at University of Toledo Toledo He did his postdoctoral fellowship 198690 at the Hormel Institute University of Minnesota the premier lipid institute He was also a research scientist at the Johns Hopkins University School of Medicine 19982002 Currently he is the Chairperson of Education of the Davis Heart Lung Research Institute of the Ohio State University He has published nearly 70 peerreviewed papers was author of five book chapters and edited a book on Free Radicals and Antioxidant Protocols He has teaching and mentoring experience of more than 16 years and mentored over 40 students He served as an editor of the Chemical Abstracts of the American Chemical Society He was one of the members in International Academy of Oral Medicine Toxicology He served as a reviewer of peerreviewed journals in the area of cell biology and Lipidomics He has been on the editorial board of the World Journal of GI Pharmacology He organized many conferences He received many awards like Distinguished Mentor Award in 2008 and Distinguished Undergraduate Mentor Award in 2009 of the Ohio State University

Lipidomics approach of studying the regulation of phospholipases under oxidative and nitrative stress in the vascular endothelium and respiratory tract epithelium; Lipid signaling mechanism of inflammatory cytokine release in respiratory epithelium exposed to inhaled toxicants; Heavy metal toxicity to endothelial and epithelial systems and membrane lipid signaling; Synthesis, analysis, and biological activity of oxidized phospholipids, oxylipid signal mediators, oxidized sugar and lipid conjugates; Lipid mediators in adipose during sleep apnea; Phospholipidomics and eicosanomics of chronic lung diseases.

Dr. Fadi Khasawneh earned a BSc in Pharmacy from Jordan University of Science and Technology and a PhD in Pharmacology from the University of Illinois at Chicago Chicago Illinois USA Currently he is an Assistant Professor in Western University of Health Sciences College of Pharmacy Department of Pharmaceutical Sciences in Pomona California USA He has published many peerreviewed papers in prominent journal and presented his work at many national and international meetings. He was a member in the Scientific Research Society Sigma Xi the American Society for Pharmacology and Experimental Therapeutics and the The American Society of Hematology. He serves as a reviewer of peerreviewed journals in the area of platelet biology pharmacology and thrombosis particularly work related to the lipid thromboxane A2. He also reviewed books such as the second edition of the Principles of Pharmacology The Pathophysiologic Basis of Drug Therapy by David Golan He received many awards like a predoctoral fellowship from the American Heart Association a Young Scientist Travel Award from the American Society for Pharmacology and Experimental Therapeutics and more recently he received funding from the TobaccoRelated Disease Research Program

The role of the lipid mediator known as thromboxane A2 and its receptor in the pathogenesis of thrombosis-based disorders. Mapping of the G-protein coupling domains of the thromboxane A2 receptor, as well as repurposing old drugs for new uses (i.e., drug rediscovery).

Dr Reinhold Did His BS 1959 University of New Hampshire MS 1961 University of New Hampshire PhD 1965 University of Vermont Atomic Energy Commission Fellow 19661968 Brookhaven National Laboratories Helen Hay Whitney Fellow 19691972 Joint Appointment MITHarvard University Research Associate MIT 19731975 DRR Mass Spectrometry Facility Lecturer in Biological Chemistry and Molecular Biology 19761996 Harvard Medical School Director Mass Spectrometry Facility 19851996 Harvard School of Public Health Professor in Microbiology 19961998 Boston University Medical School Adjunct Professor in Microbiology 1998present Boston University Medical School Research Professor in Chemistry Biochemistry 1998present University of New Hampshire Director Center for Structural Biology 2001present University of New Hampshire

His focused strongly on methods development in past years and more recently on application of these strategies and techniques to relate carbohydrate detailed structure to function. For reasons of sensitivity and specificity these methods depend heavily on mass spectrometry and their adjunct techniques. Latest studies have involved the use of ion trapping to determine carbohydrate structures where specific ions are selected for activation, collision, and measurement multiple times, MSn. This ability to isolate substructures for further characterization has become of vital importance to understand the detailed linkage and branching patterns inherent in lipid and protein glycosylation.

John S Davis Did his Graduate Training PhD in Physiology University of North Dakota Grand Forks North Dakota PostDoctoral Fellowship Reproductive Biology and Biochemistry The Endocrine Laboratory Department of Biochemistry University of Miami School of Medicine Miami Florida

Biochemistry, Reproductive biology, Medicine

Michael H Davidson MD is a Clinical Professor at the University of Chicago where he also serves as Director of Preventive Cardiology and Associate Vice Chairman for Continuing Medical Education In addition he is Founder President and Chief Executive Officer of the Chicago Center for Clinical Research currently part of Radiant Research Dr Davidson earned his medical degree from The Ohio State University College of Medicine in Columbus He then fulfilled his residency in internal medicine at RushPresbyterianSt Luke′s Medical Center in Chicago where he later completed a fellowship in cardiologyAn active researcher Dr Davidson′s clinical research background encompasses both pharmaceutical and nutritional clinical trials His extensive research on statins novel lipidlowering drugs and non pharmacologic risk factor reduction has established him as a key opinion leader in this area A prolific author and lecturer on lipid disorders nutrition and atherosclerosis Dr Davidson has coordinated more than 1000 clinical trials in areas of preventive cardiology and published more than 250 articles for leading medical journals and has written 3 books on Lipidology Dr Davidson is boardcertified in internal medicine cardiology and clinical lipidology He is a Fellow of the American College of Cardiology and the American College of Chest Physicians In addition he is President 20092010 of the National Lipid Association He was named in The Best Doctors in America 20032010 and was named Father of the Year by the American Diabetes Association 2010

Internal Medicine, Cardiology, and Clinical Lipidology, Statins, Novel Lipid-lowering drugs.

Sriram Neelamegham is a Professor of Chemical and Biological Engineering and codirector of the Center for Biomedical Engineering at the State University of New York Buffalo USA He earned his PhD at the Rice University Houston in the field of Chemical/Biomedical Engineering and he performed postdoctoral research in the field of leukocyte biology at the Baylor College of Medicine Houston He has published over 50 peerreview journal articles and additional book chapters and patents His teaching experience spans more than 12 years He serves as a reviewer of peerreview journals in the areas of bioengineering systems biology vascular biology hematology cell and glycol biology He is also a standing member of the NIH study section on Hypertension and Microcirculation Dr Neelamegham has received various awards including the University at Buffalo Young Investigator Award and the NHLBI Independent Scientist Award

Systems level investigations of glycosylation reaction networks: both experimental and theoretical; Studies of glycosyltransferases and O-glycans; Strategies to regulate leukocyte adhesion to vascular endothelium; Mathematical modeling of biochemical reaction networks; Effect of hydrodynamic shear stress in regulating protein structure and function; adhesion.

Dr Rajendran Did his BS PhD from University of Madras and joined as a faculty member in West Virginia University at present he is a professor of biochemistry

Our laboratory is interested in investigating the electrolyte transport processes that regulate colonic fluid movement during physiological and pathophysiological (diarrhea and ulcerative colitis) conditions. We focus to identify the Ca2+-activated intermediate conductance (also known as KCNN4) K+ channel isoform that provides the driving force for Cl- secretion in several fluid secreting epithelial cells. To achieve this goal, we employ electrophysiology, biochemical, molecular and biophysical techniques.

Dr. Andrzej Kloczkowski did his MSc Chemistry Warsaw University Poland 1974 his PhD Physical Chemistry Institute of Physical Chemistry of the Polish Academy of Sciences Warsaw Poland 1980 and his DSc Habilitation Physical Chemistry Warsaw University Poland 2001 Postdoctoral Fellow Stanford University 19811983 At present he is a Adjunct Professor of Iowa State University

My research interests focus on various aspects of computational molecular biology and structural bioinformatics, Lattice models of proteins, Prediction of protein structures, Protein dynamics, Prediction of protein functions, Protein packing and statistical potentials, Prediction of binding sites, prediction of phosphorylation sites, Systems Biology.

Dr Igor C Almeida did his PHD In Microbiology and ImmunologyEscola Paulista de MedicinaEPM currently UNIFESP Sao Paulo Brazil1994 Master of ScienceMolecular BiologyEscola Paulista de Medicina EPM currently Federal University of Sao Paulo Brazil 1989 Pharmacy degreeUniversidade Regional do Nordeste currently UEPb Campina Grande PB Brazil1981

Biochemical and Immunological aspects of the parasite Trypanosoma cruzi

Dr SukHee Lee did Postdoctoral Fellowship SloanKettering Cancer Institute New York NY 19871991 and his PhD University of Texas Austin Texas 1987 at present he is working as faculty member of Indiana University school of Medicine

Identifiation and characterization of potential target protein(s) involved in the regulation of DNA replication.
Analyses of the molecular mechanisms that regulate DNA replication in response to extracellular signals, particularly DNA damage

Nikolaus Gassler is Professor for Pathology in the Institute of Pathology at the RWTH Aachen University Germany He earned his MD at the University Leipzig and his MA at the FernUniversity Hagen Currently he is the leader of the research area Molecular and Ultrastructural Pathology and head senior physician in the Institute of Pathology at the RWTH Aachen He has published a high number of original work reviews and book chapters He has been teaching experience of more than twenty years He is a fellow of the International Academy of Pathology and served as a reviewer of peerreviewed journals in the area of gastrointestinal cell biology and Lipidomics

Lipidomics approach for studying the regulation of long-chain-CoA thioesters under control of respective enzymes like acyl-CoA synthetases (ACSLs) in epithelial cells of gut and liver; Lipid based signaling and mechanisms of lipoapoptosis.

Dr. Antonio Andrés graduated from Complutensis University of Madrid (Spain) with a BSc degree in Biology. He earned in 1981 his Ph.D. in Biochemistry based on metabolic regulation studies at Autonomous University of Madrid (Spain). The Fullbright Commission funded post-doctoral training at Mount Sinai School of Medicine, Department of Pathology N.Y. (USA) working on coated vesicles proteins and function. He moved in 1984 to the Department of Molecular Biology at the Centre of Molecular Biology “Severo Ochoa” in Madrid, where he started to study the molecular mechanisms of insulin resistance with ageing. As Associate Professor he moved in 1992 to the University of Castilla-La Mancha (Ciudad Real, Spain) where is currently Professor of Biochemistry and Molecular Biology, and member of the Regional Center for Biomedical Research. He has published over 60 original research papers, reviews and book chapters. He has been teaching experience of more than 25 years and served as a reviewer of peer-reviewed journals in the area of Endocrinology and Molecular and Cellular Biology of Lipids.   

Crosstalk between insulin and leptin signaling on glucose and lipid metabolism in
obesity and type 2 diabetes.

Effects of hypothalamic adipokines administration on glucose and lipid metabolism
in peripheral tissues.
 

Glycoananlysis, Biological sciences

Dr Lavie graduated from Louisiana State University Medical School in 1983 and received the Physiology and Cardiology awards and performed his internship and residency in internal medicine at the Ochsner Medical Institutions. He subsequently completed a fellowship in cardiovascular diseases at the Mayo Graduate School of Medicine where he also served as a member of the faculty in 1989 He is boardcertified in internal medicine cardiovascular diseases and nuclear cardiology.

Vascular Status, Physical Function, and Healthy Aging. Uncovering genetic influences on healthy aging, with a decided focus on the investigation of health and quality of life particularly in those over 90 years of age. Health Benefits of Aerobic and resistance Training in individuals with type 2 diabetes, Cancer Survival through Weight Loss and Exercise, Prognostic Value of Non-Invasive Data for Cardiovascular Diseases.

Dr Mechref′s lab is focusing their research on glycomics and glycoproteomics in search for biomarkers to more accurately detect cancers and track their progression Prostate cancer is one of the major points of study within the lab because the standard assay used to test for prostate cancer is at best 50 accurate Dr Mechref and his colleagues are out to increase those odds By tracking glycoproteins Dr Mechref has the ability to identify cancers earlier in their proliferation In the interview we went into Dr Mechref′s many appointments As the Director of the METACyt Biochemical analysis center Dr Mechref is developing high resolution and ultra sensitive bio anylnyltical separation techniques As glycobiologists continue to hone their craft and look deeper into the functions on a cellular level they are continually in need of higher specificity with their lab tools And Dr Mecref is heading up these developments

Cancer Biomarkers, Mutational Research

Aindrila Mukhopadhyay received an MSc in Chemistry from the Indian Institute of Technology, Bombay, and has a PhD in Organic Chemistry from the University of Chicago. She is a Staff Scientist in the Physical Biosciences Division at the Lawrence Berkeley National Laboratory, where she leads a multidisciplinary team to study stress response in bacteria using microbiological, biochemical and systems biology tools. Dr. Mukhopadhyay is the Director of Omics studies and the Co-director of Microbial Fuels transport at the Joint BioEnergy Institute in Emeryville, CA. Her projects include the study of two component signal transduction systems in the anaerobic sulfate reducing bacterium Desulfovibrio vulgaris Hildenborough as part of the Environmental Stress Pathway Project (ESPP). She utilizes a wide variety of cell wide studies in environmentally important bacteria such as D. vulgaris, and in engineered fuel production microbes such as E. coli and S. cerevisiae. In the study of metabolically engineered microbes, Dr Mukhopadhyay focuses on the role of efflux pumps as a mechanism to relieve toxicity from metabolite accumulation and increasing titer of metabolite production.

Study of Two component signal transduction systems in Desulfovibrio vulgaris Hilden borough Microbial Fuels Transport at JBEI: The Role of efflux pumps in Escherichia coli solvent resistance Omics Research at JBEI

Chryssostomos Chatgilialoglu (born 1952) is director of research at the Consiglio Nazionale delle Ricerche (Bologna) since 1991. He was the winner of the Reagent of the Year 1990.  Author and editor of 4 books, author and co-author of over 240 papers, and invited speaker over 160 times at congresses and institutions. He is the Chairman of the COST Action on Free Radicals in Chemical Biology. He is President and co-founder of the spin-off company Lipinutragen

Free radical reactions and in the last decade have been increasingly addressed to applications in life sciences, such as biomimetic chemistry of radical stress and related biomarkers.

Sergei is a broadly trained biophysical scientist who joined PharmaDiagnostics in 2010 from the Biodesign Institute at Arizona State University (Phoenix, USA). There he was an Associate Professor and Director of the Microarray Facility leading a group involved in the applications of nanoparticles in large scale biological screening assays. Prior to this role, Sergei held the position of Senior Scientist in a private biopharmaceutical company developing small molecule pan-selectin inhibitors that have now reached Phase II clinical studies for the treatment of vaso-occlusive crisis of sickle cell disease.

Novel multivalent platforms for tailoring tumor-associated antigens onto the surface of metal and semiconductor nanocrystals. These nano-sized constructs were successfully used as anti-metastatic and cancer imaging beacons

Dr Anna Kashina compleated her BS Biochemistry Moscow State University 1986 MS Biochemistry Moscow State University 1987 and her PhD Cell Biology Moscow Institute for Protein Research 1993 now she is now working as Associate Professor of Biochemistry University of Pennsylvania

Protein modifications, mouse genetics, cancer, cytoskeleton, cardiovascular development, angiogenesis.

Judith Aponte is a Specialization Coordinator of the Community/Public Health Nursing MS Program and of the Community/Public Health Nursing/Urban Public Health MS/MPH Graduate Program HunterBellevue School of Nursing HBSON Hunter College City University of New York CUNY Associate Professor HBSON Hunter College CUNY Dr Aponte received a DNSc in Nursing from Columbia University New York NY NY in 2004 she completed her MSN in Nursing Administration in 1998 and her BSN in 1994 from HBSON NY NY She has reviewed manuscripts of peerreviewed journals on topics related to diabetes The journals include the Revista Panamericana de Salud Publica/Pan American Journal of Public Health and the Hispanic Health Care International HHIC journals Dr Aponte has numerous publications international presentations and has conducted research on diabetes and its risk factors specifically as it affects the Hispanic population She is one of the few US researchers whose work has acknowledged Hispanics as a heterogeneous not homogeneous group and diabetesrelated issues that affect different Hispanic subgroups a step that is critical to identifying disparities and understanding differences among the subgroups in order to develop targeted interventions that promote optimum health and minimize complications

Diabetes and Diabetes-related Risk Factors Hispanic Subgroups Community

Nancy A. Rice completed her Postdoctoral studies from University of Colorado and working as an associate professor  in Western Kentucky University

Molecular, Cellular and Developmental Biology, Interactions of the subunit of phosphorylase-b kinase

Domenico Pratico MD University of Rome La Sapienza Rome Italy 1986 Internship Hospital of the University of Rome at La Sapienza Residency Hospital of the University of Rome at La Sapienza 1986 to 1991 Fellowship Hemocoagulation Hospital of the University of Rome at La Sapienza 1990 to 1991; Cardiovascular Science University of Dublin Ireland 1992 to 1994

Dr. Praticos′ research area is clinical pharmacology with a special focus on the cellular and molecular aspects of cell oxidative biology and a particular interest in small molecules such as bioactive oxidized lipids.

My laboratory studies inflammatory mechanisms involved in the development of atherosclerosis. Oxidized lipoproteins profoundly change the function of macrophages in atherosclerotic lesions. We study the role of 12/15-lipoxygenase and Toll-like receptors in the macrophage inflammatory responses. The hypothesis being tested is that 12/15LO-mediated modification of LDL produces ligands that activate TLR4 and other cellular receptors.

Macrophage signaling pathways and gene expression, macropinocytosis and phagocytosis of apoptotic cells as characteristics of macrophage activation in vascular inflammation.A new exciting direction in our research is studying the processes of vascular inflammation in zebrafish. The optical transparency of zebrafish larvae enables monitoring vascular lipid and macrophage accumulation in real time in a live animal. This opens endless possibilities for in vivo functional studies of certain processes of atherogenesis.

Kiyoko F. Aoki-Kinoshita is an associate professor in the Department of Bioinformatics at Soka University, Japan. She earned her Ph.D. in Computer Engineering at Northwestern University in Evanston, IL, USA, after which she was employed at BioDiscovery, Inc. and later at the Bioinformatics Center at Kyoto University. She has published research articles in data mining and bioinformatics techniques pertaining to carbohydrate structures, written several book chapters, and she is the author of the book "Glycome Informatics: Methods and Applications". She has served on the board of the Japanese Society for Bioinformatics, and she has served as a reviewer of peer-reviewed journals in the area of bioinformatics and glycobiology.

Glycan structure profiles and recognition patterns of lectins and other glycan-binding proteins, data mining of complex carbohydrates, web-based resource development including databases and web services pertaining to carbohydrate structure and related data.

Masanori Yamaguchi is Associate Professor of the Faculty of Education, Wakayama University. He received his Ph. D. from the Faculty of Agriculture, Gifu University, in 2004 for studies on the organic synthesis of selectin ligands. In 2008 he became a member of the Faculty of Education, Wakayama University and became Associate Professor of Organic Chemistry in 2010. He served as one of the managers of The Chemical Society of Japan. He served as a reviewer of peer reviewed journals in the area of glycobiology and bio-organic chemistry.

Synthetic approach toward the biologically active carbohydrates, focusing on problems in glycobiology related to viral infection, cancer, immune response, etc, and applications in medicinal chemistry.

He belongs to the Department of Anatomy National University of Singapore, Singapore

Role of phospholipases A2 in neurodegeneration, Role of metals in neurodegeneration, Role of lipids in neurodegeneration, Orofacial pain mechanisms, Health effects of engineered nanomaterials

Brian Giunta was born in Atlanta Georgia and received his BS in Microbiology in 1999 from the University of South Florida USF in Tampa Florida As an undergraduate Dr Giunta received a Florida Academic Scholarship and was inducted into both the USF College of Arts and Sciences Honor Society and the Golden Key International Honors Society During this time he also worked as an organic chemist developing adenosine receptor antagonists at the Suncoast Cardiovascular Research Lab located at the USF College of Medicine Following graduation Dr Giunta attended medical school at USF and receviecd his medical degree in 2004 As a medical student Dr Giunta was the recipient of the Anthony J Reading MD Award for Outstanding Fourth Year Student in Psychiatry and the Gold Humanism in Medicine Honor Society Award After completing Psychiatry Internship at Duke University Dr Giunta returned to the University of South Florida and was selected to participate in the K30 Scholars Program in Clinical and Translational Research and attained a Masters Degree in Medical Science with a concentration in clinical and translational researchIn 2007 Dr Giunta received a Future Leader in Psychiatry Award from Emory University and a Young Investigator Award in Drug Discovery Development and Regulatory Affairs from the American Society for Pharmacology and Experimental TherapeuticsDr Giunta is Director of the Neuroimmunology Laboratory in the Department of Psychiatry and Neurosciences and currently his research is focused on developing natural compounds for the treatment of neuroinflammatory dementias particularly HIVassociated dementia and Alzheimers Disease In 2008 he received a Mentored Clinical Scientist Development Award from the NIH/NIMH entitled The Role of HIV1 Tat in Alzheimers Disease The goal of this project is to determine whether greentea EGCG is effective in a novel mouse model of HIV1 Tat induced Alzheimers Pathology

Translational research leading to clinical trials on the interactions between the immune, neuroendocrine and nervous systems in various psychiatric disorders including HIV-1 dementia and Alzheimer’s Disease.

Robert C Block, MD MPH FACP is a graduate of Cook College at Rutgers University New Brunswick New Jersey where he received a Bachelor of Arts in Political Science with a Minor in Environmental Sciences. He received his Medical Degree from New Jersey Medical School within the University of Medicine and Dentistry of New Jersey He completed a Transitional Medicine Internship at the Kalamazoo Center for Medical Studies at Michigan State University and then an Internal Medicine Residency at the Mayo Graduate School of Medicine in Rochester Minnesota Dr Block completed a Masters of Public Health an NHLBIsponsored PostDoctoral Fellowship in Cardiovascular Epidemiology and Biostatistics/Preventive Cardiology T32 and a K30 Certificate in Clinical Research all at the University of Rochester School of Medicine and Dentistry Dr Block is currently an Assistant Professor in the Division of Epidemiology Department of Community and Preventive Medicine at the University of Rochester He carries secondary appointments in the Cardiology Division within the Department of Medicine where he practices preventive cardiology and clinical Lipidology and is a Diplomate of the American Board of Clinical Lipidology His preventive cardiology practice draws patients from as far East as Utica South as far as the Pennsylvania border and West as far as the Buffalo region He also holds a secondary appointment in the Center for Community Health at the University of Rochester Dr Block is Director of the Upstate New York Translational Research Network a consortium of sixteen Upstate New York institutions supported by the University of Rochester’s Clinical and Translational Science Institute He is Director of the Cardiovascular Disease Epidemiology and Prevention Course and CoDirector of the Chronic Disease Epidemiology and Prevention Course in the Graduate Education Programs within the Department of Community and Preventive Medicine Dr Block has been Principal Investigator for a local clinical trial sponsored by the University of Rochester’s Clinical and Translational Science Institute investigating the synergistic effects of omega3 fatty acids and aspirin on platelet function in healthy individuals He is the recipient of a Career Development Award in Clinical and Translational Research from the University of Rochester’s Clinical and Translational Science Institute Dr Block is currently Principal Investigator for a National Heart Lung and Blood Institutesponsored R21 clinical trial and a GlaxoSmithKlinesponsored clinical trial both focused on the synergistic effects of omega3 fatty acids and aspirin on platelet function in individuals with diabetes mellitus and acute coronary syndromes Dr Block has published many primary research and review papers in peerreviewed journals as well as book chapters focused on cardiovascular disease prevention

Practice in preventive cardiology and clinical Lipidology

Jordi B. Torrelles is an Assistant Professor of Internal Medicine at The Ohio State University. He joined the faculty since 2008 and is past recipient of the James V. Warren Award as recognition of outstanding and excellence in research performed in the Department of Internal Medicine at The Ohio State University and also the Parker B. Francis Fellowship in pulmonary research. He obtained his M.Sc. in clinical microbiology and his Ph.D. in biochemistry and microbiology from the “Universitat Autonoma de Barcelona”, Catalonia, Spain, performing his studies in the Mycobacteria Research Laboratories at Colorado State University studying Mycobacterium tuberculosis cell envelope biochemistry. He did his postdoctoral training at The Ohio State University where he started his work on innate immunity focusing on Mycobacterium tuberculosis pathogenesis.

His laboratory is focused on understanding M. tuberculosis and host interactions at the molecular, biochemical and cellular levels. In particular, his interest is on how the structure of the cell envelope of the Mycobacterium tuberculosis bacillus is affected by the lung alveolar microenvironment and how this may affect the outcome of M. tuberculosis infection.

Dr. John A McLean was an assistant professor of chemistry in vanderbilt university

Our research focuses on the design, construction, and application of advanced technologies for structural mass spectrometry, in particular, for studies in structural proteomics, systems biology, and biophysics. To identify and structurally characterize biomolecules from complex samples, we perform rapid (µs-ms) two-dimensional gas-phase separations using ion mobility-mass spectrometry (IM-MS) techniques.

Professor ship in Bryant University and Has vast knowledge in Science and Technology

Translational research leading to clinical trials on the interactions between the immune

Dr. Farahnaz Movahedzadeh is Assistant Professor at Institute for Tuberculosis Research (ITR), College of Pharmacy at University of Illinois at Chicago (UIC). She earned her Ph.D. from the University College of London (UCL) and National Institute for Tuberculosis Research (NIMR) in England. Currently, she is a Biology Instructor at City College of Chicago and a Research Assistant Professor at UIC. She has published many reviewed papers, and she was author of 6 book chapters. She has teaching experience of more than 10 years. She served as the member of National Association of Biology Teachers (NABT), Association of College and University Biology Educators (ACUBE), Acid-Fast Club, UK and International union Against Tuberculosis and Lung Disease (IUATLD).She served as a reviewer of peer-reviewed journals, in the area of molecular and microbiology, and a grant reviewer of NIH. She organized the first hybrid conference on “Hybrid learning” at City College of Chicago in 2009. She received awards from different organizations including WHO and SENCER. She is also the recipient of grants from ALA, CBC and NSF.

Molecular genetics of Mycobacterium tuberculosis, essential genes, latency, virulence, gene regulation and expression, gluconeogenesis, and identification of novel drug targets.

My PhD is in Nutrition in Sports and Chronic Disease from Virginia Tech, focused on using nutrition to influence oxidative stress and inflammation in the chronic disease of obesity.  I conducted a variety of human studies including weight loss trials and controlled feeding studies of various durations.  Through my postdoc at the Virginia College of Osteopathic Medicine I gained extensive experience in a basic science laboratory working with an inflammatory mouse model and cell cultures (immune cells, fat cells).  I am now an Assistant Professor at the University of Cincinnati with the broad goal of researching the interaction between diet and inflammation in chronic diseases such as obesity and diabetes. 

Nutrition plays a key role in the development of chronic diseases and inflammation has been identified as a key underlying factor of many chronic diseases that is heavily influenced by diet.  I am studying the effects of heart healthy dietary patterns on inflammation.  I am interested in how intake of antioxidants, vitamins/minerals, phytochemicals, fiber, and unsaturated fats may reduce inflammation in addition to reducing risk factors for cardiovascular disease.

She Belongs to the Department of Biochemistry Virginia Commonwealth University Richmond

Biochemistry, Medical Strategies

Regulation of transcription in eukaryotes, role of nuclear receptors and coregulators in epigenetic, regulation of chromatin in normal and diseased states.

Carbohydrate virus receptors

(1) elucidating the role of lipid-mediated injury of retinal pigment epithelial cells and how this injury promotes pathogenic changes in Bruch’s membrane and drusen formation, through activation of receptors including the nuclear receptors, peroxisome proliferator activated receptors and (2) investigating the role of pro-inflammatory M1 macrophages and mechanisms by which these effector cells of immunity are recruited to and retained in ‘injured’ retina, contributing to further morphological and functional damage. Our most recent studies have focused on osteopontin and its receptors, recently identified in several degenerative diseases of aging functioning to direct in situ localization of macrophages

Ron Orlando did his PhD from University of Delaware 1988

Our research focuses on the use of mass spectrometry to answer biological/biomedical questions. The majority of our projects involve characterizing the post-translational modifications (e.g., glycosylation, phosphorylation) present on the protein of interest. For example, we are currently investigating the in vivo changes that occur in human eye lenses upon normal aging and cataract formation. We hope that this research ultimately will provide a mechanism to prevent cataracts.

Bernd Lepenies is the head of the Glycoimmunology research group at Max Planck Institute of Colloids and Interfaces Potsdam Germany He earned his PhD at the Bernhard Nocht Institute for Tropical Medicine in Hamburg Germany with Highest Distinction Following his postdoctoral research in the Laboratory for Organic Chemistry Swiss Federal Institute of Technology ETH Zurich group of Prof Peter Seeberger he became a group leader at Max Planck Institute in 2009 Currently his research is funded by a grant from the German Federal Ministry of Education and Research BMBF Dr Lepenies is a member of the American Chemical Society the International Endotoxin Innate Immunity Society the German Society for Immunology and the German Society for Biochemistry and Molecular Biology He served as a reviewer of peerreviewed journals in the area of immunology and glycomics research

•    C-type lectin receptors in infection and inflammation
•    Utilization of carbohydrate-protein interactions for specific targeting of tissues and organs (i.e. targeted drug delivery, development of new adjuvants)

Endocrine Research at UCSD is particularly strong and includes basic translational and clinical research components

Glycomics, genomics, and biochemistry approaches to study plant cell wall polysaccharide and proteoglycan metabolism. One of the most important differences between plant and animal cells is that plant cells have an extra-cellular structure called the cell wall that surrounds the protoplast. For plants, cell wall controls growth, morphogenesis, and interactions with the environment. For humans, cell wall polysaccharides and proteoglycans are important raw materials in the wood, paper, textile, fuel, and food industries. Thus, a good understanding of the biosynthesis of these macromolecules is a crucial step to improve plant development and production as a sustained source for our needs. The other area of research focuses on elucidating the role of the cross talk between the cell wall and the plasma membrane. This interaction can be crucial regulatory events for important physiological processes. We are interested in a subgroup of proteoglycans from plants called fasciclin-like arabinogalactan-proteins that are though to be involved in such interaction.

Rafat Siddiqui have earned my BSc 1978 MSc 1980 degrees in Biochemistry with First Class first Position from the University of Karachi, Karachi, Pakistan. I obtained my PhD in 1988 from the Australian National University Canberra Australia During my PhD I investigated the metabolic basis of cancer cachexia under the supervision of Professor John F Williams who is famous for his research on the pentose phosphate pathway I served as a postdoctoral fellow 19871989 in Dr Stuart McCutcheons Currently Vice Chancellor Auckland University New Zealand laboratory at Massey University Palmerton North New Zealand I immigrated to America in 1989 on an invitation from Dr John Exton on a Howard Hughes Medical Institute HHMI fellowship at Vanderbilt University Medical Center Vanderbilt University Nashville Tennessee I started my research work in the Bone Marrow Transplant Research Laboratory at Methodist Hospital in 1993 where I established my independent research laboratory in 1999 At present I am a Senior Investigator and the Director of the Cellular Biochemistry Research Laboratory at the Methodist Research Institute I also have an adjunct Professor appointment in the Department of Biology Indiana University, Purdue University Department of Medicine Indiana University Medical School Indianapolis IndianaDuring the course of my scientific career I have developed broad expertise in the life science research area However my research is primarily focused to investigate how dietary fats impact diseases particular cardiovascular and cancer I have developed a very successful research program at the Methodist Research Institute in the area of molecular nutrition In the cardiovascular area I am studying how omega3 fatty acids and trans fatty acids effect vascular remodeling and functions My work published in this area was included in the top 5 articles in the area of cardiovascular research for the Annual Bibliography of Significant Advances in Dietary Supplement Research 2006 Office of the Dietary Supplements National Institute of Health Bethesda Maryland Similarly my notable contribution in the cancer area is the development of fatty acidspolyphenol conjugates with anticancer properties This work has also received a worldwide attention

My research interest is to understand the mechanisms by which lipid and lipid-derived mediators impact the development cardiovascular disease and cancer, and to develop new therapies and dietary recommendations to improve outcomes.

Dr Andrews received his PhD in New Zealand at the University of Otago in 2003 and has 10 years experience in the field of neuroendocrinology and neuroscience. From there, he went on to do postdoctoral training at Yale University, New Haven, Connecticut, USA (2004-2008) where he was awarded a prestigious New Zealand Foundation for Research Science and Technology Postdoctoral Fellowship. Yale University is considered one of the world′s leading universities through a proven ability to consistently recruit world-leading scientists/educators/academics that publish constantly in top class journals and develop breakthrough technologies. During his time at Yale, Dr Andrews had to fortune to imbibe the atmosphere of one of the world′s leading universities and was exposed to cutting-edge research that helped to focus his scientific ambitions to pursue a position as an active academic researcher. He has published in the world′s leading journals including Nature, Cell Metabolism, Neuron, Journal of Clinical Investigation and the Journal of Neuroscience. His work has attracted significant public interest, including invitation to write for Scientific Amercian and Australasian Science. Dr Andrews was interviewed by and included in an article entitled 13 things you never knew about your weight in the recent edition of The Reader′s Digest (January 2009). Dr Andrews came to Monash University late in 2008 as a Monash Fellow and has started to establish his own research program. He uses a combination of genetic mouse models (global knockouts, conditional knockouts using the cre/lox system) and in vivo physiology to probe questions about how metabolic status affects neuronal metabolism and degeneration.

Dr. Andrews studies how the brain regulates food intake and body weight during different metabolic states and in response to different endocrine environments. His particular interest involves mitochondrial mechanisms regulating neuronal metabolism and neuroprotection. He is an expert on the neuroendocrine actions of ghrelin in the brain.

Laura Bindila is Scientist within Luxembourg Clinical Proteomics laboratory, at the Centre de Recherche Publique de la Sante, Strassen, Luxembourg. She carried out her PhD program at University of Munster, Institute for Medical Physics and Biophysics and defended her thesis at the Babes Bolyai University of Cluj Napoca, Romania. She continued her potdoctoral and scientific career at the University of Munster till January 2010 when she moved to Luxemborug Clinical Proteomics laboratory. She has published more than 25 articles, including reviews. She has teaching experience of more than 5 years. She is member of graduate school in Molecular and Cellular Glyco-Sciences (University of Munster) and served as member in Erasmus exchange programs between european universities. She served as a reviewer of peer-reviewed journals in the area of glycobiology, lipidomics and proteomcis. She is member of organizing committee of the Summer School for Mass Spectrometry in Biotechnology and Medicine. She received the Summa cum laudae title for her PhD thesis and was awarded earlier in her career with the "Putting CE to work" prize.

Glycomics, glycoproteomics and (glyco)lipidomics approaches for disease associated biomarker discovery and monitoring; structural diversity underlinig the glycan functionality in biological processes.

Leucocyte research and molecular and chemical patterns

Dr Thomas O Metz is a Senior Research Scientist in the Biological Sciences Division of Pacific Northwest National Laboratory located in Richland WA USA He earned his PhD in Chemistry at the University of South Carolina and subsequently completed a postdoctoral appointment at PNNL He has published 29 peerreviewed papers and 2 book chapters and is a member of the American Chemical Society American Society for Mass Spectrometry the Metabolomics Society and the International Maillard Reaction Society

Metabolomics and lipidomics methods development and applications in disease and fundamental research; Systems Biology; Role of the Maillard reaction in the development of diabetic complications

He belongs to the Dyslipdemies Inflammation et atherosclerose dans les maladies metabolities pavillon Benjamin delessert

He belongs to Institute of Molecular Pathology and Immunology (IPATIMUP), University of Porto

Molecular pathology, immunology

Dr Jozef Nahalka is independent researcher in Department of Glycochemistry, Center for Glycomics, Institute of Chemistry, Slovak Academy of Sciences, Slovakia. He earned his Ph.D. at Slovak University of Technology, Bratislava. Currently, he is the principal investigator of one Slovak, one bilateral and one EU projects. He has published 21 Reviewed papers, and he was author of 1 book chapter.

Enzymatic synthesis of oligosaccharides; enzyme and lectin engineering, design of synthetic enzyme pathways for glyco-synthesis by omics data analysis.

He belongs to the FRSC Institut fur Bioanalytische Chemie Universitat des Saarlandes Campus B2 2, Raum 2.27Rapid Communications in mass Spectrometry

Molecular pathology, immunology

He belongs to the Department of Medicinal Chemistry University of Kansas Becker Drive Lawrence KS

Chemistry, Medical Chemistry

She belongs to the Department of Pathology School of medicine Emory University

Pathology, Medicine and disease education

He belongs to the Life Science Institute National University of Singapore

Life science & Pathological studies.

Dr Yan Liu was faculty member of medicine in imperial college

Carbohydrate microarray, neoglycolipid, pandemic influenza A (H1N1) 2009 virus, pathogen–host interaction, sialic acid, Toxoplasma gondi.